Pogostone
 | |
| Names | |
|---|---|
| Preferred IUPAC name
4-hydroxy-6-methyl-3-(4-methylpentanoyl)pyran-2-one | |
| Other names
Dhelwangin
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChemSpider | |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C12H16O4 | |
| Molar mass | 224.256 g·mol−1 |
| Appearance | Colorless needles |
| Melting point | 32–33 °C (90–91 °F; 305–306 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Pogostone or dhelwangin is a naturally occurring organic compound with the formula C12H16O4. Classified as a secondary metabolite, primarily found in patchouli, a member of the mint family Lamiaceae.[1] This plant has historically been used in traditional Chinese medicine to treat ailments such as the common cold, nausea, diarrhea, headache, and fever,[2] and is also applied for its antifungal properties.[3] Pogostone was first identified in 1969 as the major antimicrobial constituent of Pogostemonis Herba, the dried aerial parts of patchouli used in herbal preparations.[4]
Structure and properties
[edit]Pogostone has the molecular formula C12H16O4.[1][5] Pogostone (PO) was obtained as needle-like colorless crystals.[5] Its melting point was reported as 32–33 °C.[5] It features a 2H-pyranone core and was first structurally characterized by X-ray crystallography, which also revealed the presence of intramolecular hydrogen bonding.[5]
Due to its low natural abundance in the plant, synthetic methods for pogostone production have been developed.[1] One synthetic route involves the condensation of dehydroacetic acid (DHA) with aldehydes in dry tetrahydrofuran (THF) under nitrogen at low temperature (0–5 °C), followed by hydrogenation, chromatography, and crystallization.[1][5] The reaction proceeds via deprotonation, Michael addition reaction, tautomerization, and further deprotonation steps.[5] Two diastereomeric dimers of pogostone, with (8S,9R) and (8S,9S) configurations, have also been synthesized and structurally confirmed by nuclear magnetic resonance and X-ray diffraction.[5]
Applications
[edit]The development of synthetic routes for pogostone and its analogues facilitates their potential application as novel antifungal agents, particularly in the treatment of azole-resistant Candida albicans infections.[1] Its anti-inflammatory activity also supports further exploration as a therapeutic agent for conditions such as septic shock.[6] However, its inhibitory effects on major cytochrome P450 enzymes warrant caution and further study regarding possible drug–drug interactions.[7]
References
[edit]- ^ a b c d e Yi, Yu-Yang; He, Jing-Jin; Su, Jun-Quan; Kong, Song-Zhi; Su, Ji-Yan; Li, Yu-Cui; huang, Si-Han; Li, Chu-Wen; Lai, Xiao-Ping; Su, Zi-Ren (2013-01-01). "Synthesis and antimicrobial evaluation of pogostone and its analogues". Fitoterapia. 84: 135–139. doi:10.1016/j.fitote.2012.11.005. ISSN 0367-326X. PMID 23160088.
- ^ Pharmacopoeia of the People's Republic of China. Vol. 3, vol. 1, Chinese Pharmacopoeia Commission ([9. ed.], English version 2010 ed.), Beijing: China Medical Science Press, 2010, pp. 42–373, ISBN 978-7-5067-5005-9
{{citation}}: CS1 maint: others (link) - ^ Miyazawa, Mitsuo; Okuno, Yoshiharu; Nakamura, Sei-ichi; Kosaka, Hiroshi (2000-03-01). "Antimutagenic Activity of Flavonoids from Pogostemon cablin". Journal of Agricultural and Food Chemistry. 48 (3): 642–647. Bibcode:2000JAFC...48..642M. doi:10.1021/jf990160y. ISSN 0021-8561. PMID 10725128.
- ^ Klein, E; Rojahn, W (1969-06-01). "[Isolation, structure and synthesis of dhelwangin]". Tetrahedron Letters (27): 2279–2280. doi:10.1016/s0040-4039(01)88141-7. ISSN 0040-4039. PMID 5796586.
- ^ a b c d e f g Zhao, Xiaoning; Li, Chuwen; Cao, Yongkai; Yi, Yuyang; Shi, Shujiang; Feng, Xuexuan; Su, Ziren; Zeng, Huifang (2014-01-24). "Structural elucidation of Pogostone and its dimers-two novel diastereomers combined with X-ray diffraction and spectroscopy". Journal of Molecular Structure. 1058: 189–196. Bibcode:2014JMoSt1058..189Z. doi:10.1016/j.molstruc.2013.10.054. ISSN 0022-2860.
- ^ Li, Yu-Cui; Xian, Yan-Fang; Su, Zi-Ren; Ip, Siu-Po; Xie, Jian-Hui; Liao, Jin-Bin; Wu, Dian-Wei; Li, Chu-Wen; Chen, Jian-Nan; Lin, Zhi-Xiu; Lai, Xiao-Ping (2014-11-18). "Pogostone suppresses proinflammatory mediator production and protects against endotoxic shock in mice". Journal of Ethnopharmacology. 157: 212–221. doi:10.1016/j.jep.2014.09.023. ISSN 1872-7573. PMID 25256685.
- ^ Zhang, Guiying; Zhang, Yanping; Ma, Xianjie; Yang, Xin; Cai, Yuyan; Yin, Wenli (2021). "Pogostone inhibits the activity of CYP3A4, 2C9, and 2E1 in vitro". Pharmaceutical Biology. 59 (1): 530–534. doi:10.1080/13880209.2021.1917630. ISSN 1388-0209. PMC 8871619. PMID 33915070.